System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Denis Jullien is an expert in Dermatology at Hôpital Édouard-Herriot (France). As of October 2026, ScienceLeadR ranks Denis Jullien in the top 1% of experts worldwide for Psoriasis and Skin Diseases, Papulosquamous. Denis Jullien has authored 450 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 1,046 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Denis Jullien Hôpital Édouard-Herriot France
1 046 ScienceLeadR Reputation 1046

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Public Health - Infectiology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026
Source: PubMed

Hôpital Édouard-Herriot

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 450

Citations

Citations: 11 635 1st author: 40 Last author: 50 Unique author: 9

Main journals

Ann Dermatol Venereol 127
J Eur Acad Dermatol Venereol 56
Annales de dermatologie et de vénéréologie, FMC 22
Annales de Dermatologie et de Vénéréologie - FMC 18
Br J Dermatol 18

Best Journals

Lancet 1
Lancet Rheumatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Facial discoid dermatosis successfully treated with topical ruxolitinib: A case report.
PMID 42892895 — pityriasis rubra pilaris, skin diseases		JAAD Case Rep20260
Real-world epidemiology and management of patients with rheumatoid arthritis treated with methotrexate in France: a decade after methotrexate first recommendations.
PMID 42857275 — epidemiology, arthritis, arthritis, rheumatoid, therapeutics, methotrexate		EULAR Rheumatol Open20260
Line-field confocal optical coherence tomography for lichenoid dermatoses: A pilot study.
PMID 42671163 — dermatomyositis, pilot projects, sexually transmitted diseases, pilots, lupus erythematosus, cutaneous, tomography, skin diseases, tomography, optical coherence, lichen planus		J Eur Acad Dermatol Venereol20260
Real-World Treatment Patterns, Healthcare Resource Utilisation, and Costs in Biologic-Naïve Patients with Moderate-to-Severe Psoriasis Treated with Biologics in France.
PMID 42622792 — therapeutics, psoriasis		Dermatol Ther (Heidelb)20260
Perturbation of nuclear proteins by optogenetic trapping in Drosophila ovary.
PMID 42616014 — cells, nuclear proteins, transcription factors, ovary, cell biology, cluster analysis, optogenetics		J Cell Biol20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 5
N/A 3
Phase 4 1

By status:

Completed 5
Recruiting 2
Unknown 2

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to learn how safe bimekizumab is and how well it works in adults with palmoplantar pustulosis
2024-520337-80-00 — safety		Phase 3Recruiting2026
VAC WARTS
2024-513671-40-00 — vaccines, warts, therapeutics		Phase 3Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS